PharmaShots | Incisive News in 3 Shots

Subscribe Now

Regulatory

argenx and Zai Lab Report the NMPA’s Approval of Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

argenx and Zai Lab Report the NMPA’s Approval of Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

November 12, 2024

Atamyo Therapeutics Reports the US FDA’s IND Clearance of ATA-200 for Treating Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5)

Atamyo Therapeutics Reports the US FDA’s IND Clearance of ATA-200 for Treating Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R...

November 12, 2024

Autolus Therapeutics’ Aucatzyl (Obecabtagene Autoleucel) Receives the UA FDA’s Approval to Treat R/R B-Cell Acute Lymphoblastic Leukemia

Autolus Therapeutics’ Aucatzyl (Obecabtagene Autoleucel) Receives the UA FDA’s Approval to Treat R/R B-Cell Acute Lymphoblastic Le...

November 11, 2024

PharmaShots Weekly Snapshots (November 04 – November 08, 2024)

PharmaShots Weekly Snapshots (November 04 – November 08, 2024)

November 11, 2024

AskBio’s AB-1003 Secures the US FDA’s Rare Pediatric Disease and Orphan Drug Designations to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9

AskBio’s AB-1003 Secures the US FDA’s Rare Pediatric Disease and Orphan Drug Designations to Treat Limb-Girdle Muscular Dystrophy...

November 8, 2024

Dizal Reports the Regulatory Submission of Sunvozertinib to the US FDA for Treating R/R Non-Small Cell Lung Cancer

Dizal Reports the Regulatory Submission of Sunvozertinib to the US FDA for Treating R/R Non-Small Cell Lung Cancer

November 8, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us